Neos Therapeutics IPO Research Information

Neos Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Neos Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Neos Therapeutics	NEOS - NASDAQ	$14.00-$16.00	$15.00	$18.22	4.8 million	7/23/2015
Underwriter(s): UBS Investment Bank, BMO Capital Markets, RBC Capital Markets
Co-Manager(s): JMP Securities
Industry: Health Care
Filing(s): Filed 2015-06-19 Terms Added 2015-07-13

Neos Therapeutics Quote & Chart - Click for current quote - NEOS

About Neos Therapeutics (adapted from Neos Therapeutics prospectus):
They are a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing our proprietary modified-release drug delivery technology platform, which we have already used to develop our three branded product candidates for the treatment of attention deficit hyperactivity disorder, or ADHD.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "NEOS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.